Viavi Solutions Inc.
$8.20B- Market cap
- $8.61B
- Debt
- +$244.80M
- Cash
- −$649.80M
Capital structure 97% equity / 3% debt · EV / Revenue 5.40x · EV / EBITDA 66.90x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 ·
Decision snapshot: VIAV stock price at premium vs CAH $34.88 current versus $1.39 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CAH's multiple
Implied fair value · at VIAV's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: VIAV FY 2026 (ended Jun 27, 2026) · CAH FY 2026 (ended Jun 30, 2026). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 97% equity / 3% debt · EV / Revenue 5.40x · EV / EBITDA 66.90x
Capital structure 87% equity / 13% debt · EV / Revenue 0.24x · EV / EBITDA 15.83x
CAH carries the larger enterprise value at $61.53B against $8.20B; CAH trades on the lower EV / Revenue multiple (0.24x vs 5.40x); CAH on the lower EV / EBITDA (15.83x vs 66.90x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Viavi Solutions Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Cardinal Health, Inc. · implied price per share
Bear
$208.52
Base
$255.23
Bull
$319.63
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.17x
-3.08x
Net debt / EBITDA
Leverage against operating earnings
-3.30x
1.04x
Cash and equivalents
Liquid reserves on the balance sheet
$649.80M
$4.86B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Broadcom Inc.
VIAV vs AVGO
TEXAS INSTRUMENTS INC
VIAV vs TXN
ANALOG DEVICES INC
VIAV vs ADI
SKYWORKS SOLUTIONS, INC.
VIAV vs SWKS
Qorvo, Inc.
VIAV vs QRVO
Marvell Technology, Inc.
VIAV vs MRVL
MCKESSON CORP
VIAV vs MCK
AmerisourceBergen Corporation
VIAV vs ABC
Walgreens Boots Alliance, Inc.
VIAV vs WBA
CVS Health Corporation
VIAV vs CVS
HENRY SCHEIN INC
VIAV vs HSIC
$244.80M
$8.89B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.